Asthma Implementation Research Trial (AIRE)
Primary Purpose
Asthma, Asthma in Children
Status
Completed
Phase
Not Applicable
Locations
Peru
Study Type
Interventional
Intervention
Self-management Intervention Package
Sponsored by

About this trial
This is an interventional health services research trial for Asthma focused on measuring Implementation Science, Global Health, Peru
Eligibility Criteria
Inclusion Criteria:
- Currently living in Lima, Peru
- 5-17 years of age
- Has a physician diagnosis of asthma
- Has attended the emergency room or urgent care for asthma, or has been hospitalized for asthma at least once in the previous 12 months
Exclusion Criteria:
- Family plans to move out of the study community within the next 12 months
- Co-occurring chronic respiratory or cardiovascular disorders other than asthma
- Active tuberculosis or are currently taking tuberculosis medications
- Diagnosis of HIV/AIDS
Sites / Locations
- Hospital Nacional Cayetano Heredia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Enhanced care
Arm Description
The intervention arm will receive a multi-faceted self-management intervention package.
The control arm will receive usual care plus basic asthma education from a trained nurse educator.
Outcomes
Primary Outcome Measures
Change in Asthma Control as assessed by Childhood Asthma Control Test (cACT) Score
cACT (5-11 years of age) will be administered at baseline and monthly during the follow-up period. The cACT is scored by summing the scores for all items. Overall scores ranges from 0 to 27. Lower scores indicate poorer asthma control and higher scores indicate better asthma control. Scores 19 and below suggest impaired asthma control.
Change in Asthma Control as assessed by Asthma Control Test (ACT) Score
ACT (12-17 years of age) will be administered at baseline and monthly during the follow-up period. The ACT is scored by summing the scores for all items. Overall score ranges from 5 to 25. Lower scores indicate poorer asthma control and higher scores indicate better asthma control. Scores 19 and below suggest impaired asthma control.
Number of participants with at least one asthma-related ED or urgent care visit during the six-month follow-up period
Number with asthma-related emergency department (ED) or urgent care visits will be used to assess healthcare utilization.
Secondary Outcome Measures
Change in Adherence to Refills and Medications Scale-7 (ARMS-7) score
ARMS-7 will administered at baseline and monthly during the follow-up period. Score is calculated by summing the scores for all items. Overall score ranges between 7 and 28. Lower scores indicate better adherence.
Medication adherence as assessed by Dose counter-measured medication use
Number of puffs used divided by the number of puffs indicated to be used over monthly follow-up period.
Quality of life as assessed by Pediatric Asthma Quality of Life Questionnaire (PAQLQ)-Mini
Measures disease-specific quality of life in children and adolescents with asthma. The PAQLQ-mini has 13 items, each scored on a 7-point Likert scale with "1" indicating severe impairment and "7" indicating no impairment. Score is calculated by taking the average of scores for each item. Higher scores indicate better quality of life. Range: [1 to 7].
Quality of life in caregivers of children and adolescents with asthma as assessed by Pediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ)
Measures quality of life in caregivers of children and adolescents with asthma. The PACQLQ has 13 items, each scored on a 7-point Likert scale with "1" indicating severe impairment and "7" indicating no impairment. Score is calculated by taking the average of scores for each item. Higher scores indicate better quality of life. Range: [1 to 7].
Depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Measures depressive symptoms. Will be administered to caregivers of children and adolescents with asthma. The PHQ-9 has nine items, each scored on a Likert scale from 0 to 3. Higher scores indicate more evidence of depressive disorder of greater severity of disorder. Scores are calculated by summing the scores for all items. Range: [0 to 27].
Number of participants with asthma-related hospitalizations
Count of participants (children) with at least one asthma-related hospitalization during six-month follow-up period.
Number of participants with all-cause emergency department (ED) or urgent care visits
Count of participants with at least one all-cause ED or urgent care visit during the six-month follow-up period.
Number of participants who attend two or more outpatient appointments with healthcare provider for asthma.
Count of participants who attend two or more outpatient appointments with healthcare provider for asthma over six-month follow-up period.
Full Information
NCT ID
NCT03986177
First Posted
June 11, 2019
Last Updated
May 28, 2020
Sponsor
Johns Hopkins University
Collaborators
Asociacion Benefica Prisma, Hospital Nacional Cayetano Heredia, American Thoracic Society
1. Study Identification
Unique Protocol Identification Number
NCT03986177
Brief Title
Asthma Implementation Research Trial
Acronym
AIRE
Official Title
Implementation of a Community Intervention to Improve Asthma Self-Management Practices in Peru
Study Type
Interventional
2. Study Status
Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
June 3, 2019 (Actual)
Primary Completion Date
March 30, 2020 (Actual)
Study Completion Date
March 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
Asociacion Benefica Prisma, Hospital Nacional Cayetano Heredia, American Thoracic Society
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Asthma is the most common chronic disease among children worldwide, with 80% of asthma related deaths occurring in low- and middle-income countries (LMICs), such as Peru. While evidence-based guidelines exist for asthma treatment and management, adherence to guideline-based practices is low in high-income country (HIC) and LMIC settings alike. There a clear need for effective, locally-tailored solutions to address the asthma treatment gap in low-income communities in LMICs, such as Peru. This study aims to develop and test a locally-adapted intervention package to improve adoption of self-management practices and utilization of preventive health services for asthma among children in Lima. There is a paucity of research regarding the development and testing of interventions to improve asthma self-management in LMIC settings, which experience unique or exacerbated barriers to receiving evidence-based care. To the investigators' knowledge, no studies have systematically developed and evaluated an asthma management program in Peru. Therefore, the long-term goal of this study is to disseminate locally appropriate asthma management strategies to reduce asthma-related emergency department visits and improve service utilization in LMIC settings. For the current study, the investigators will carry out a randomized controlled trial to test the effectiveness of the intervention package in a group of 110 children with asthma who will be randomized to the intervention (55 children) or no intervention (55 children) arm. Participants in the intervention group will receive case management from a designated nurse manager, who will provide ongoing educational, social, and self-management support during monthly follow-up home visits and text-message based communication. Participants will be followed up every month for data collection over a six-month period. Throughout the follow-up period, the investigators will collect data on asthma control, healthcare utilization, medication adherence, quality of life of children with asthma and the children's caregivers, caregiver mental health, fidelity to the intervention, and acceptability and feasibility. Ultimately, this study will inform the scientific community about effective strategies and treatment programs for asthma in low-income settings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma, Asthma in Children
Keywords
Implementation Science, Global Health, Peru
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
110 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
The intervention arm will receive a multi-faceted self-management intervention package.
Arm Title
Enhanced care
Arm Type
No Intervention
Arm Description
The control arm will receive usual care plus basic asthma education from a trained nurse educator.
Intervention Type
Behavioral
Intervention Name(s)
Self-management Intervention Package
Intervention Description
Children will receive basic asthma education, based on the National Heart, Lung, and Blood Institute "A Breath of Life" asthma education program. Children/caregivers in the intervention arm will also be assigned a designated nurse case manager who will provide home visits and be available via text message and phone-based support throughout follow-up. Intervention components:
Interactive education and support on use of an asthma action plan
Locally adapted patient-provider communication tool
Child-oriented educational materials in comic book format
Modeling and hands-on practice of inhaler technique (written instructions, in person, video)
Education regarding environmental trigger abatement
Patient navigation, home visits, and goal setting support from nurse manager
Primary Outcome Measure Information:
Title
Change in Asthma Control as assessed by Childhood Asthma Control Test (cACT) Score
Description
cACT (5-11 years of age) will be administered at baseline and monthly during the follow-up period. The cACT is scored by summing the scores for all items. Overall scores ranges from 0 to 27. Lower scores indicate poorer asthma control and higher scores indicate better asthma control. Scores 19 and below suggest impaired asthma control.
Time Frame
Baseline, then monthly up to 6 months
Title
Change in Asthma Control as assessed by Asthma Control Test (ACT) Score
Description
ACT (12-17 years of age) will be administered at baseline and monthly during the follow-up period. The ACT is scored by summing the scores for all items. Overall score ranges from 5 to 25. Lower scores indicate poorer asthma control and higher scores indicate better asthma control. Scores 19 and below suggest impaired asthma control.
Time Frame
Baseline, then monthly up to 6 months
Title
Number of participants with at least one asthma-related ED or urgent care visit during the six-month follow-up period
Description
Number with asthma-related emergency department (ED) or urgent care visits will be used to assess healthcare utilization.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in Adherence to Refills and Medications Scale-7 (ARMS-7) score
Description
ARMS-7 will administered at baseline and monthly during the follow-up period. Score is calculated by summing the scores for all items. Overall score ranges between 7 and 28. Lower scores indicate better adherence.
Time Frame
Baseline, then monthly up to 6 months
Title
Medication adherence as assessed by Dose counter-measured medication use
Description
Number of puffs used divided by the number of puffs indicated to be used over monthly follow-up period.
Time Frame
6 months
Title
Quality of life as assessed by Pediatric Asthma Quality of Life Questionnaire (PAQLQ)-Mini
Description
Measures disease-specific quality of life in children and adolescents with asthma. The PAQLQ-mini has 13 items, each scored on a 7-point Likert scale with "1" indicating severe impairment and "7" indicating no impairment. Score is calculated by taking the average of scores for each item. Higher scores indicate better quality of life. Range: [1 to 7].
Time Frame
6 months
Title
Quality of life in caregivers of children and adolescents with asthma as assessed by Pediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ)
Description
Measures quality of life in caregivers of children and adolescents with asthma. The PACQLQ has 13 items, each scored on a 7-point Likert scale with "1" indicating severe impairment and "7" indicating no impairment. Score is calculated by taking the average of scores for each item. Higher scores indicate better quality of life. Range: [1 to 7].
Time Frame
6 months
Title
Depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Description
Measures depressive symptoms. Will be administered to caregivers of children and adolescents with asthma. The PHQ-9 has nine items, each scored on a Likert scale from 0 to 3. Higher scores indicate more evidence of depressive disorder of greater severity of disorder. Scores are calculated by summing the scores for all items. Range: [0 to 27].
Time Frame
6 months
Title
Number of participants with asthma-related hospitalizations
Description
Count of participants (children) with at least one asthma-related hospitalization during six-month follow-up period.
Time Frame
6 months
Title
Number of participants with all-cause emergency department (ED) or urgent care visits
Description
Count of participants with at least one all-cause ED or urgent care visit during the six-month follow-up period.
Time Frame
6 months
Title
Number of participants who attend two or more outpatient appointments with healthcare provider for asthma.
Description
Count of participants who attend two or more outpatient appointments with healthcare provider for asthma over six-month follow-up period.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Currently living in Lima, Peru
5-17 years of age
Has a physician diagnosis of asthma
Has attended the emergency room or urgent care for asthma, or has been hospitalized for asthma at least once in the previous 12 months
Exclusion Criteria:
Family plans to move out of the study community within the next 12 months
Co-occurring chronic respiratory or cardiovascular disorders other than asthma
Active tuberculosis or are currently taking tuberculosis medications
Diagnosis of HIV/AIDS
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suzanne Pollard, PhD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Nacional Cayetano Heredia
City
Lima
Country
Peru
12. IPD Sharing Statement
Citations:
PubMed Identifier
32366314
Citation
Romani ED, Siddharthan T, Lovaton N, Alvitez-Luna CC, Flores-Flores O, Pollard SL. Implementation of an intervention to improve the adoption of asthma self-management practices in Peru: Asthma Implementation Research (AIRE) randomized trial study protocol. Trials. 2020 May 4;21(1):377. doi: 10.1186/s13063-020-4207-5.
Results Reference
derived
Learn more about this trial
Asthma Implementation Research Trial
We'll reach out to this number within 24 hrs